chronic hepatitis B
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 65 years, non-limited gender; 2. History of HBV or HBsAg positive>6 months up to now; 3. Three months around Fibrotouch, with qualified liver biopsy for pathological diagnosis is accepted; 4. without chemical therapy history of powerful medicine to lower enzyme in the two weeks before blood biochemical detection.(dimethyl diphenyl bicarboxylate and bicyclol); 5. Participant agreed and signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. The people who are unable or unwilling to sign informed consent form; 2. The people who have merger of hepatitis c, alcohol and non-alcoholic fatty liver disease, autoimmune liver disease, inherited metabolic liver disease, biliary systemic disease or liver and gall parasitic diseases; 3. The people who have other serious chronic disorders or history of malignancy; 4. The people with ALT =5 ULN in the past 1 month; 5. The people with WBC<3.5×10^9/L, PLT<60×10^9/L, PTA<60%; 6. The people with DBIL=1.5 ULN; 7. The people with decompensated cirrhosis (especially the people with ascites); 8. Pregnant or lactating women, or women who have a pregnant plan and don't want to birth control in the study period; 9. The people who have wound on the right upper abdomen recently; 10. The people who have various space-occupying tumor or cyst in right liver; 11. The people who have none or limited legal capacity.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Liver stiffness value; | — |
Countries
China
Contacts
Beijing Friendship Hospital